MX9800538A - Separacion de 1-azabiciclo[2.2.2]octan-3-amina, 2-(difenilmetil)-n-[[2-metoxi-5(1-metiletil)fenil]metil]. - Google Patents

Separacion de 1-azabiciclo[2.2.2]octan-3-amina, 2-(difenilmetil)-n-[[2-metoxi-5(1-metiletil)fenil]metil].

Info

Publication number
MX9800538A
MX9800538A MX9800538A MX9800538A MX9800538A MX 9800538 A MX9800538 A MX 9800538A MX 9800538 A MX9800538 A MX 9800538A MX 9800538 A MX9800538 A MX 9800538A MX 9800538 A MX9800538 A MX 9800538A
Authority
MX
Mexico
Prior art keywords
octan
diphenylmethyl
azabicyclo
methylethyl
methoxy
Prior art date
Application number
MX9800538A
Other languages
English (en)
Other versions
MXPA98000538A (es
Inventor
Derek L Tickner
Morgan Meltz
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9800538A publication Critical patent/MX9800538A/es
Publication of MXPA98000538A publication Critical patent/MXPA98000538A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)

Abstract

Esta invencion se refiere a un procedimiento para separar 1-azabicíclico[2.2.2]octan-3-amina,2-(difenilmetil )-N-[[2-metoxi-5-(metiletil)fenil]metil] que comprende hacer reaccionar 1-azabiciclico[2.2.2]octan-3-amina,2-(difenilmetil )-N-[[2-metoxi-5-(1-meiletil)fenil]metil] con ácido 1R-(-)-10-canforsulfonico en un disolvente capaz de disolver ambos reactivos anteriores y disolver de forma selectiva la sal de ácido canforsulfonico del enantiomero (2R, 3R) correspondiente respecto al enantiomero (2S, 3S) para formar la sal del ácido canforsulfonico de (2S, 3S)-1-azabicíclico[2.2.2]octan-3-amina, 2-(difenilmetil)-N-[[2-metoxi-5-(1-metiletil)fenil ]metil], y seguidamente hidrolizar de forma opcional dicha sal para obtener la base libre del enantiomero (2S, 3S).
MXPA/A/1998/000538A 1995-07-17 1998-01-16 Separacion de 1-azabiciclo[2.2.2]octan-3-amina, 2-(difenilmetil)-n-[[2-metoxi-5(1-metiletil)fenil]metil] MXPA98000538A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US119195P 1995-07-17 1995-07-17
US001191 1995-07-17
PCT/IB1996/000648 WO1997003984A1 (en) 1995-07-17 1996-07-04 Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-n-[[2-methoxy-5-(1-methylethyl)phenyl]methyl]

Publications (2)

Publication Number Publication Date
MX9800538A true MX9800538A (es) 1998-05-31
MXPA98000538A MXPA98000538A (es) 1998-10-23

Family

ID=

Also Published As

Publication number Publication date
CZ15098A3 (cs) 1999-02-17
RU2136681C1 (ru) 1999-09-10
AR002772A1 (es) 1998-04-29
US6008357A (en) 1999-12-28
PL184261B1 (pl) 2002-09-30
NZ310539A (en) 1998-11-25
CN1190970A (zh) 1998-08-19
PT840735E (pt) 2004-02-27
PL324610A1 (en) 1998-06-08
CO4480720A1 (es) 1997-07-09
MY115734A (en) 2003-08-30
CN1068598C (zh) 2001-07-18
HUP9900238A3 (en) 2001-08-28
HK1010195A1 (en) 1999-06-17
DE69630123D1 (en) 2003-10-30
AU697553B2 (en) 1998-10-08
EP0840735A1 (en) 1998-05-13
AU6134896A (en) 1997-02-18
ZA966026B (en) 1998-01-16
KR19990029058A (ko) 1999-04-15
NO980211L (no) 1998-03-16
ES2205039T3 (es) 2004-05-01
CA2227194A1 (en) 1997-02-06
CA2227194C (en) 2002-02-12
HUP9900238A2 (hu) 1999-05-28
NO980211D0 (no) 1998-01-16
JP3043074B2 (ja) 2000-05-22
ATE250600T1 (de) 2003-10-15
DK0840735T3 (da) 2004-02-09
DE69630123T2 (de) 2004-04-08
PE8798A1 (es) 1998-03-02
KR100276989B1 (ko) 2001-01-15
JPH10511102A (ja) 1998-10-27
WO1997003984A1 (en) 1997-02-06
EP0840735B1 (en) 2003-09-24
IL122655A0 (en) 1998-08-16

Similar Documents

Publication Publication Date Title
ATE199542T1 (de) Verfahren zur herstellung von amorphem (r-(r*, r*))-2-(4-fluorphenyl)-beta,delta-dihydroxy-5-( - methylethyl)-3-phenyl-4-((phenyl-amino)carbonyl - 1h-pyrrol-1-heptansäure-calciumsalz (2:1)
DE3855458D1 (de) Verfahren zur herstellung von conformationnell stabilisierten zelladhäsionspeptiden
RU94004977A (ru) Соединения с сульфамоильной и амидино-группой, способ их получения и содержащие их фармацевтические композиции
CA2008391A1 (en) 1,2-cyclohexylaminoaryl amides useful as analgesic agents
AU5812400A (en) Carrier-drug conjugate
GR3034942T3 (en) Enzymatic processes for resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes.
HUP0103432A3 (en) Calcium (3s) tetrahydro-3-furanyl(1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-(phosphonooxy) propylcarbamate, pharmaceutical composition containing the compound and process for preparation the same
GR3032772T3 (en) (r)-(z)-1-azabicyclo 2.2.1]heptan-3-one,o- 3-(3-methoxyphenyl)-2-propynyl]oxime maleate as a pharmaceutical agent
IN184142B (es)
AU2460900A (en) Shortened-chain polynucleotides and process for the preparation thereof
CA2243534A1 (en) Process for the preparation of d-threo-(r,r)-methylphenidate and recycling of undesired enantiomers by epimerisation
CA2272716A1 (en) Resolution of ritalinic acid salt
MY115734A (en) Resolution of 1-azabicyclo (2.2.2.) octon -3-amine, 2-(diphenylmethyl)-n- [[2-methoxy-5-(1-mehtylethyl) phenyl]methyl]
CA2132982A1 (en) Catalytic antibodies against cocaine and methods of using and producing same
PT983238E (pt) Processos e intermediarios para a resolucao dos estereoisomeros de piperidil-acetamida
IT8922075A0 (it) Processo per l'inversione stereochimica di (2s,3s)-2-ammino-3-fenil-1 ,3-propandioli nei corrispondenti enantiomeri (2r,3r)
ATE207895T1 (de) Thermostabile und lagerfähige kristallmodifikation von n-methyl-n-((1s)-1- phenyl-2-((3s)-3-hydroxypyrrolidin-1-yl)-ethyl) 2,2-diphenyl-acetamid und verfahren zu dessen herstellung
GEP19991790B (en) C-2’ Hydroxyl-Bezyl Protected, N-Carbamate Protected (2R,3S)-3-Phenylisoserine and Production Process Therefor
EP0725142A4 (en) METHOD FOR PRODUCING D-AMINO ACID BY A COMPOSED IMMOBILIZED ENZYME COMPOUND
DE69520947D1 (de) Diarinopropanole abgeleitet von aminosäuren
ATE435228T1 (de) Verfahren zur herstellung von 2-methylspiro(1,3- oxathiolan-5,3')chinuclidin
FR2750435B1 (fr) Procede de formation de complexes d'hybridation dont la stabilite depend peu de la composition en base des deux molecules d'acides nucleiques hybridees
FR2788271B1 (fr) Nouveau procede de preparation d'aminoacides chiraux
CA2302011A1 (en) Process for enhancing the optical purity of 2r-[1-hydroxy-1-trifluoromethyl-3-cyclopropylpropyn-2yl]-4-chloroaniline
AU658215B2 (en) Process for the resolution of enantiomers of 5-heteroaryl-1,3,4-thiadiazinones

Legal Events

Date Code Title Description
FG Grant or registration